| ADNYX | VMGIX | ADNYX / VMGIX | |
| Total Expense Ratio | 1.14 | 0.19 | 600% |
| Annual Report Gross Expense Ratio | 1.25 | 0.19 | 658% |
| Fund Existence | 9 years | 20 years | - |
| Gain YTD | 5.933 | 9.670 | 61% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 3000 | 3,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 166M | 33.8B | 0% |
| Annual Yield % from dividends | 0.00 | 0.50 | - |
| Returns for 1 year | 20.58 | 12.42 | 166% |
| Returns for 3 years | 94.59 | 55.05 | 172% |
| Returns for 5 years | -50.74 | 31.72 | -160% |
| Returns for 10 years | N/A | 211.76 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNSX | 78.27 | 1.43 | +1.86% |
| Janus Henderson Global Life Sciences S | |||
| ANPRX | 32.69 | N/A | N/A |
| Virtus NFJ Mid-Cap Value R6 | |||
| VESGX | 52.92 | N/A | N/A |
| Vanguard Global ESG Select Stk Admiral | |||
| LFGVX | 46.54 | N/A | N/A |
| Lord Abbett Focused Growth R6 | |||
| GFACX | 72.91 | -0.39 | -0.53% |
| American Funds Growth Fund of Amer C | |||